{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T13:01:23Z","timestamp":1784811683001,"version":"3.55.0"},"reference-count":149,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100019693","name":"UFFS","doi-asserted-by":"publisher","award":["PES-2024-0533"],"award-info":[{"award-number":["PES-2024-0533"]}],"id":[{"id":"10.13039\/100019693","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"CNPq","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005667","name":"FAPESC","doi-asserted-by":"publisher","award":["2023TR001508"],"award-info":[{"award-number":["2023TR001508"]}],"id":[{"id":"10.13039\/501100005667","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005667","name":"FAPESC","doi-asserted-by":"publisher","award":["2024TR002554"],"award-info":[{"award-number":["2024TR002554"]}],"id":[{"id":"10.13039\/501100005667","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.ejphar.2026.179036","type":"journal-article","created":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T06:50:50Z","timestamp":1779864650000},"page":"179036","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Antidepressant effect of psychedelic compounds and mechanisms underlying the G protein-coupled receptors activation psychedelics: Antidepressant action and GPCR signaling"],"prefix":"10.1016","volume":"1029","author":[{"given":"Amanda","family":"Gollo Bertollo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinicius","family":"Alexandre Wippel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maiqueli","family":"Eduarda Dama Mingoti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Daniel Prediger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1417-1308","authenticated-orcid":false,"given":"Zuleide","family":"Maria Ign\u00e1cio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2026.179036_bib1","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/j.tips.2021.08.003","article-title":"Neuroplasticity as a convergent mechanism of ketamine and classical psychedelics","volume":"42","author":"Aleksandrova","year":"2021","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejphar.2026.179036_bib2","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/j.1600-0447.1964.tb04952.x","article-title":"Therapeutic application of the change in consciousness produced ry PSYCHOLYTICA (LSD, PSILOCYRIN, ETC.)1: the psychedelic experience in the treatment of neurosis","volume":"39","author":"Aln\u00e6s","year":"1964","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.ejphar.2026.179036_bib3","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/j.bcp.2005.12.022","article-title":"A role for AMPA receptors in mood disorders","volume":"71","author":"Alt","year":"2006","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.179036_bib4","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/s41591-018-0011-0","article-title":"Antidepressive effects of targeting ELK-1 signal transduction","volume":"24","author":"Apazoglou","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejphar.2026.179036_bib5","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.pharmthera.2012.09.006","article-title":"Serotonin receptors involved in antidepressant effects","volume":"137","author":"Artigas","year":"2013","journal-title":"Pharmacol. Ther."},{"issue":"Suppl 3","key":"10.1016\/j.ejphar.2026.179036_bib6","first-page":"S32","article-title":"Serotonin selective antidepressant drugs: past, present, future","volume":"16","author":"Asberg","year":"1993","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.ejphar.2026.179036_bib7","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.neuropharm.2018.08.032","article-title":"Evidence for intact 5-HT1A receptor-mediated feedback inhibition following sustained antidepressant treatment in a rat model of depression","volume":"141","author":"Babb","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2026.179036_bib8","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3949\/ccjm.92a.24032","article-title":"Psychedelic-assisted therapy: an overview for the internist","volume":"92","author":"Barnett","year":"2025","journal-title":"Cleve. Clin. J. Med."},{"key":"10.1016\/j.ejphar.2026.179036_bib9","doi-asserted-by":"crossref","DOI":"10.3389\/fnrgo.2021.784576","article-title":"Human cortical serotonin 2A receptor occupancy by psilocybin measured using [11C]MDL 100,907 dynamic PET and a resting-state fMRI-Based brain parcellation","volume":"2","author":"Barrett","year":"2022","journal-title":"Front. Neuroergonomics"},{"key":"10.1016\/j.ejphar.2026.179036_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajp.2024.104242","article-title":"Exploring the regulatory framework of psychedelics in the US & Europe","volume":"102","author":"Behera","year":"2024","journal-title":"Asian J. Psychiatry"},{"key":"10.1016\/j.ejphar.2026.179036_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuroimage.2019.116240","article-title":"The structure of the serotonin system: a PET imaging study","volume":"205","author":"Beliveau","year":"2020","journal-title":"Neuroimage"},{"key":"10.1016\/j.ejphar.2026.179036_bib12","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1001\/archpsyc.1994.03950090019003","article-title":"Mood-lowering effect of tryptophan depletion: enhanced susceptibility in young men at genetic risk for major affective disorders","volume":"51","author":"Benkelfat","year":"1994","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.ejphar.2026.179036_bib13","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.tips.2005.10.008","article-title":"Physiological relevance of constitutive activity of 5-HT2A and 5-HT2C receptors","volume":"26","author":"Berg","year":"2005","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejphar.2026.179036_bib14","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1111\/j.1440-1819.2009.02030.x","article-title":"Resting state default\u2010mode network connectivity in early depression using a seed region\u2010of\u2010interest analysis: decreased connectivity with caudate nucleus","volume":"63","author":"Bluhm","year":"2009","journal-title":"Psychiatr. Clin. Neurosci."},{"key":"10.1016\/j.ejphar.2026.179036_bib15","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2012.00116","article-title":"Resting-state functional connectivity in late-life depression: higher global connectivity and more long distance connections","volume":"3","author":"Bohr","year":"2013","journal-title":"Front. Psychiatr."},{"key":"10.1016\/j.ejphar.2026.179036_bib16","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/pcn.12604","article-title":"Neural basis of major depressive disorder: beyond monoamine hypothesis","volume":"72","author":"Boku","year":"2018","journal-title":"Psychiatr. Clin. Neurosci."},{"key":"10.1016\/j.ejphar.2026.179036_bib17","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.3390\/cells10081902","article-title":"Serotonin heteroreceptor complexes and their integration of signals in neurons and astroglia\u2014relevance for mental diseases","volume":"10","author":"Borroto-Escuela","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.ejphar.2026.179036_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.nsa.2024.103986","article-title":"The prototypical hallucinogen LSD produces rapid antidepressant effects via 5-HT2B receptor activation","volume":"3","author":"Bouloufa","year":"2024","journal-title":"Neurosci. Appl."},{"key":"10.1016\/j.ejphar.2026.179036_bib19","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1124\/mol.60.6.1181","article-title":"Amphetamine, 3,4-Methylenedioxymethamphetamine, lysergic acid diethylamide, and metabolites of the catecholamine neurotransmitters are agonists of a rat trace amine receptor","volume":"60","author":"Bunzow","year":"2001","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.179036_bib20","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.phrs.2015.12.014","article-title":"The modulation of BDNF expression and signalling dissects the antidepressant from the reinforcing properties of ketamine: effects of single infusion vs. chronic self-administration in rats","volume":"104","author":"Caffino","year":"2016","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejphar.2026.179036_bib21","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/s41386-022-01389-z","article-title":"Towards an understanding of psychedelic-induced neuroplasticity","volume":"48","author":"Calder","year":"2023","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejphar.2026.179036_bib22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1000172","article-title":"Persistent cAMP-Signals triggered by internalized G-Protein\u2013Coupled receptors","volume":"7","author":"Calebiro","year":"2009","journal-title":"PLoS Biol."},{"key":"10.1016\/j.ejphar.2026.179036_bib23","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1021\/acschemneuro.2c00718","article-title":"5-HT2ARs mediate therapeutic behavioral effects of psychedelic tryptamines","volume":"14","author":"Cameron","year":"2023","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ejphar.2026.179036_bib24","doi-asserted-by":"crossref","first-page":"3154","DOI":"10.1016\/j.neuron.2022.08.006","article-title":"Signaling snapshots of a serotonin receptor activated by the prototypical psychedelic LSD","volume":"110","author":"Cao","year":"2022","journal-title":"Neuron"},{"key":"10.1016\/j.ejphar.2026.179036_bib25","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-13282-7","article-title":"Psilocybin for treatment-resistant depression: fmri-measured brain mechanisms","volume":"7","author":"Carhart-Harris","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2026.179036_bib26","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/S0006-3223(01)01083-6","article-title":"Increased hippocampal bdnf immunoreactivity in subjects treated with antidepressant medication","volume":"50","author":"Chen","year":"2001","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.ejphar.2026.179036_bib27","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s43556-023-00156-w","article-title":"Structure, function and drug discovery of GPCR signaling","volume":"4","author":"Cheng","year":"2023","journal-title":"Mol. Biomed."},{"key":"10.1016\/j.ejphar.2026.179036_bib28","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/0028-3908(84)90017-0","article-title":"Selective 5ht-2 antagonists inhibit serotonin stimulated phosphatidylinositol metabolism in cerebral cortex","volume":"23","author":"Conn","year":"1984","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2026.179036_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2020.113568","article-title":"Higher levels of serum IL-1\u03b2 and TNF-\u03b1 are associated with an increased probability of major depressive disorder","volume":"295","author":"Das","year":"2021","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.ejphar.2026.179036_bib30","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/s41591-022-01744-z","article-title":"Increased global integration in the brain after psilocybin therapy for depression","volume":"28","author":"Daws","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejphar.2026.179036_bib31","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1523\/JNEUROSCI.1659-20.2020","article-title":"Hallucinogens in mental health: preclinical and clinical studies on LSD, psilocybin, MDMA, and ketamine","volume":"41","author":"De Gregorio","year":"2021","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2026.179036_bib32","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2020705118","article-title":"Lysergic acid diethylamide (LSD) promotes social behavior through mTORC1 in the excitatory neurotransmission","volume":"118","author":"De Gregorio","year":"2021","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ejphar.2026.179036_bib33","first-page":"223","article-title":"Effects of antidepressant treatments on 5-HT neurotransmission: electrophysiological and clinical studies","volume":"39","author":"de Montigny","year":"1984","journal-title":"Adv. Biochem. Psychopharmacol."},{"key":"10.1016\/j.ejphar.2026.179036_bib34","author":"Desouza"},{"key":"10.1016\/j.ejphar.2026.179036_bib35","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2021.790213","article-title":"The hallucinogenic Serotonin2A receptor agonist, 2,5-Dimethoxy-4-Iodoamphetamine, promotes cAMP response element binding protein-dependent gene expression of specific plasticity-associated genes in the rodent neocortex","volume":"14","author":"Desouza","year":"2021","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.ejphar.2026.179036_bib36","doi-asserted-by":"crossref","first-page":"4772","DOI":"10.3390\/ijms24054772","article-title":"Depression and its phytopharmacotherapy\u2014A narrative review","volume":"24","author":"Dobrek","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2026.179036_bib37","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1097\/00005053-195812000-00006","article-title":"Psychotherapy with lysergic acid diethylamide","volume":"127","author":"Eisner","year":"1958","journal-title":"J. Nerv. Ment. Dis."},{"key":"10.1016\/j.ejphar.2026.179036_bib38","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0006-3223(03)00231-2","article-title":"Diagnosis and definition of treatment-resistant depression","volume":"53","author":"Fava","year":"2003","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.ejphar.2026.179036_bib39","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1038\/nchembio.206","article-title":"Sustained cyclic AMP production by parathyroid hormone receptor endocytosis","volume":"5","author":"Ferrandon","year":"2009","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.ejphar.2026.179036_bib40","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1021\/acsptsci.0c00063","article-title":"Structure\u2013activity relationship analysis of psychedelics in a rat model of asthma reveals the anti-inflammatory pharmacophore","volume":"4","author":"Flanagan","year":"2021","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"10.1016\/j.ejphar.2026.179036_bib41","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1177\/0269881120936486","article-title":"Changes in inflammatory biomarkers are related to the antidepressant effects of ayahuasca","volume":"34","author":"Galv\u00e3o-Coelho","year":"2020","journal-title":"J. Psychopharmacol. (Oxf.)"},{"key":"10.1016\/j.ejphar.2026.179036_bib42","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1093\/ijnp\/pyac074","article-title":"Default mode network modulation by psychedelics: a systematic review","volume":"26","author":"Gattuso","year":"2023","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.ejphar.2026.179036_bib43","doi-asserted-by":"crossref","first-page":"eaaz3140","DOI":"10.1126\/scisignal.aaz3140","article-title":"Low intrinsic efficacy for G protein activation can explain the improved side effect profiles of new opioid agonists","volume":"13","author":"Gillis","year":"2020","journal-title":"Sci. Signal."},{"key":"10.1016\/j.ejphar.2026.179036_bib44","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1016\/0024-3205(84)90436-3","article-title":"Evidence for 5-HT2 involvement in the mechanism of action of hallucinogenic agents","volume":"35","author":"Glennon","year":"1984","journal-title":"Life Sci."},{"key":"10.1016\/j.ejphar.2026.179036_bib45","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2015.00058","article-title":"New perspectives in signaling mediated by receptors coupled to stimulatory G protein: the emerging significance of cAMP e\u00ef\u00ac\u201eux and extracellular cAMP-adenosine pathway","author":"Godinho","year":"2015","journal-title":"Front. Pharmacol. 06"},{"key":"10.1016\/j.ejphar.2026.179036_bib46","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.neuron.2007.01.008","article-title":"Hallucinogens recruit specific cortical 5-HT2A receptor-mediated signaling pathways to affect behavior","volume":"53","author":"Gonz\u00e1lez-Maeso","year":"2007","journal-title":"Neuron"},{"key":"10.1016\/j.ejphar.2026.179036_bib47","doi-asserted-by":"crossref","first-page":"8836","DOI":"10.1523\/JNEUROSCI.23-26-08836.2003","article-title":"Transcriptome fingerprints distinguish hallucinogenic and nonhallucinogenic 5-hydroxytryptamine 2A receptor agonist effects in mouse somatosensory cortex","volume":"23","author":"Gonz\u00e1lez-Maeso","year":"2003","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"key":"10.1016\/j.ejphar.2026.179036_bib48","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1056\/NEJMoa2206443","article-title":"Single-dose psilocybin for a treatment-resistant episode of major depression","volume":"387","author":"Goodwin","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2026.179036_bib49","first-page":"129","article-title":"LSD-assisted psychotherapy in patients with terminal cancer","volume":"8","author":"Grof","year":"1973","journal-title":"Int. Pharmacopsychiatr."},{"key":"10.1016\/j.ejphar.2026.179036_bib50","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1038\/s41467-025-57956-7","article-title":"The structural diversity of psychedelic drug actions revealed","volume":"16","author":"Gumpper","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejphar.2026.179036_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2019.107933","article-title":"Correlation between the potency of hallucinogens in the mouse head-twitch response assay and their behavioral and subjective effects in other species","volume":"167","author":"Halberstadt","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2026.179036_bib52","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.biopsych.2011.02.003","article-title":"Default-mode and task-positive network activity in major depressive disorder: implications for adaptive and maladaptive rumination","volume":"70","author":"Hamilton","year":"2011","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.ejphar.2026.179036_bib53","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1074\/jbc.273.2.669","article-title":"The many faces of G protein signaling","volume":"273","author":"Hamm","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2026.179036_bib54","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2022489118","article-title":"Harnessing psilocybin: antidepressant-like behavioral and synaptic actions of psilocybin are independent of 5-HT2R activation in mice","volume":"118","author":"Hesselgrave","year":"2021","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ejphar.2026.179036_bib55","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s00702-024-02757-3","article-title":"Epigenetic drugs and psychedelics as emerging therapies for alcohol use disorder: insights from preclinical studies","volume":"131","author":"Hilal","year":"2024","journal-title":"J. Neural Transm. (Vienna)"},{"issue":"Suppl 6","key":"10.1016\/j.ejphar.2026.179036_bib56","first-page":"4","article-title":"History and evolution of the monoamine hypothesis of depression","volume":"61","author":"Hirschfeld","year":"2000","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.ejphar.2026.179036_bib57","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/s41380-021-01200-3","article-title":"Treatment resistance in psychiatry: state of the art and new directions","volume":"27","author":"Howes","year":"2022","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.ejphar.2026.179036_bib58","first-page":"1","article-title":"New treatment strategies of depression: based on mechanisms related to neuroplasticity","author":"Huang","year":"2017","journal-title":"Neural Plast."},{"key":"10.1016\/j.ejphar.2026.179036_bib59","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.neuroscience.2014.04.046","article-title":"Rivastigmine improves hippocampal neurogenesis and depression-like behaviors via 5-HT1A receptor stimulation in olfactory bulbectomized mice","volume":"272","author":"Islam","year":"2014","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejphar.2026.179036_bib60","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.1016\/j.neuron.2025.06.012","article-title":"The polypharmacology of psychedelics reveals multiple targets for potential therapeutics","volume":"113","author":"Jain","year":"2025","journal-title":"Neuron"},{"key":"10.1016\/j.ejphar.2026.179036_bib61","doi-asserted-by":"crossref","first-page":"6119","DOI":"10.3390\/ijms24076119","article-title":"Ginsenosides from Panax ginseng as key modulators of NF-\u03baB signaling are powerful anti-inflammatory and anticancer agents","volume":"24","author":"Jang","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2026.179036_bib62","doi-asserted-by":"crossref","first-page":"3595","DOI":"10.1038\/s41380-023-02274-x","article-title":"Mechanisms and molecular targets surrounding the potential therapeutic effects of psychedelics","volume":"28","author":"Jaster","year":"2023","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.ejphar.2026.179036_bib63","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.pscychresns.2018.03.002","article-title":"Individuals with more severe depression fail to sustain nucleus accumbens activity to preferred music over time","volume":"275","author":"Jenkins","year":"2018","journal-title":"Psychiatry Res. Neuroimaging."},{"key":"10.1016\/j.ejphar.2026.179036_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.114505","article-title":"The versatile binding landscape of the TAAR1 pocket for LSD and other antipsychotic drug molecules","volume":"43","author":"Jiang","year":"2024","journal-title":"Cell Rep."},{"key":"10.1016\/j.ejphar.2026.179036_bib65","doi-asserted-by":"crossref","first-page":"4272","DOI":"10.1038\/s41380-023-02285-8","article-title":"Effects of escitalopram on synaptic density in the healthy human brain: a randomized controlled trial","volume":"28","author":"Johansen","year":"2023","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.ejphar.2026.179036_bib66","doi-asserted-by":"crossref","first-page":"19575","DOI":"10.1073\/pnas.0905884106","article-title":"Rapid modulation of spine morphology by the 5-HT2A serotonin receptor through kalirin-7 signaling","volume":"106","author":"Jones","year":"2009","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ejphar.2026.179036_bib67","doi-asserted-by":"crossref","first-page":"R63","DOI":"10.1016\/j.cub.2021.12.009","article-title":"Psychedelics","volume":"32","author":"Kelmendi","year":"2022","journal-title":"Curr. Biol."},{"key":"10.1016\/j.ejphar.2026.179036_bib68","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1016\/j.cell.2020.08.024","article-title":"Structure of a hallucinogen-activated Gq-Coupled 5-HT2A serotonin receptor","volume":"182","author":"Kim","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.ejphar.2026.179036_bib69","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms10842","article-title":"The role of kinetic context in apparent biased agonism at GPCRs","volume":"7","author":"Klein Herenbrink","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejphar.2026.179036_bib70","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.neuron.2011.05.036","article-title":"Endocytosis promotes rapid dopaminergic signaling","volume":"71","author":"Kotowski","year":"2011","journal-title":"Neuron"},{"key":"10.1016\/j.ejphar.2026.179036_bib71","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s00213-006-0566-1","article-title":"The roles of 5-HT1A and 5-HT2 receptors in the effects of 5-MeO-DMT on locomotor activity and prepulse inhibition in rats","volume":"189","author":"Krebs-Thomson","year":"2006","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.ejphar.2026.179036_bib72","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1136\/jnnp-2011-301779","article-title":"Depression: an inflammatory illness?","volume":"83","author":"Krishnadas","year":"2012","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.ejphar.2026.179036_bib73","doi-asserted-by":"crossref","first-page":"E161","DOI":"10.1152\/ajpendo.00551.2012","article-title":"Glucagon-like peptide-1 receptor-mediated endosomal cAMP generation promotes glucose-stimulated insulin secretion in pancreatic \u03b2-cells","volume":"305","author":"Kuna","year":"2013","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.ejphar.2026.179036_bib74","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1038\/s41593-022-01177-4","article-title":"The neural basis of psychedelic action","volume":"25","author":"Kwan","year":"2022","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.ejphar.2026.179036_bib75","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2025.114940","article-title":"Psilocybin and psilocin regulate microglial immunomodulation and support neuroplasticity via serotonergic and AhR signaling","volume":"159","author":"Laabi","year":"2025","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.ejphar.2026.179036_bib76","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1038\/nchembio.2431","article-title":"A kinetic view of GPCR allostery and biased agonism","volume":"13","author":"Lane","year":"2017","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.ejphar.2026.179036_bib77","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222413387","article-title":"GPCRs are optimal regulators of complex biological systems and orchestrate the interface between health and disease","volume":"22","author":"Leysen","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2026.179036_bib78","article-title":"Trace amine-associated receptors as potential targets for the treatment of anxiety and depression","volume":"16","author":"Li","year":"2025","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.179036_bib79","doi-asserted-by":"crossref","first-page":"305","DOI":"10.3389\/fncel.2017.00305","article-title":"From serotonin to neuroplasticity: evolvement of theories for major depressive disorder","volume":"11","author":"Liu","year":"2017","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.ejphar.2026.179036_bib80","first-page":"1","article-title":"The role of neural plasticity in depression: from hippocampus to prefrontal cortex","volume":"2017","author":"Liu","year":"2017","journal-title":"Neural Plast."},{"key":"10.1016\/j.ejphar.2026.179036_bib81","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1684\/ecn.2015.0362","article-title":"TNF\u03b1 mediates stress-induced depression by upregulating indoleamine 2,3-dioxygenase in a mouse model of unpredictable chronic mild stress","volume":"26","author":"Liu","year":"2015","journal-title":"Eur. Cytokine Netw."},{"key":"10.1016\/j.ejphar.2026.179036_bib82","series-title":"Behavioral Neurobiology of Psychedelic Drugs","first-page":"45","article-title":"Hallucinogens and serotonin 5-HT2A receptor-mediated signaling pathways","author":"L\u00f3pez-Gim\u00e9nez","year":"2017"},{"key":"10.1016\/j.ejphar.2026.179036_bib83","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1210\/me.2013-1314","article-title":"Minireview: more than just a hammer: ligand \u201cBias\u201d and pharmaceutical discovery","volume":"28","author":"Luttrell","year":"2014","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.ejphar.2026.179036_bib84","doi-asserted-by":"crossref","first-page":"3170","DOI":"10.1016\/j.celrep.2018.05.022","article-title":"Psychedelics promote structural and functional neural plasticity","volume":"23","author":"Ly","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.ejphar.2026.179036_bib85","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1038\/s41386-019-0324-9","article-title":"Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels","volume":"44","author":"Madsen","year":"2019","journal-title":"Neuropsychopharmacol. Off. Publ. Am. Coll. Neuropsychopharmacol."},{"key":"10.1016\/j.ejphar.2026.179036_bib86","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/nature19112","article-title":"Structure-based discovery of opioid analgesics with reduced side effects","volume":"537","author":"Manglik","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2026.179036_bib87","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1038\/s41380-021-01040-1","article-title":"Update on GPCR-based targets for the development of novel antidepressants","volume":"27","author":"Mantas","year":"2022","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.ejphar.2026.179036_bib88","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00607-2020","article-title":"Pathogenesis of COVID-19 from a cell biology perspective","volume":"55","author":"Mason","year":"2020","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.ejphar.2026.179036_bib89","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1038\/s41386-020-0718-8","article-title":"Me, myself, bye: regional alterations in glutamate and the experience of ego dissolution with psilocybin","volume":"45","author":"Mason","year":"2020","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejphar.2026.179036_bib90","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1002\/wps.21120","article-title":"Treatment\u2010resistant depression: definition, prevalence, detection, management, and investigational interventions","volume":"22","author":"McIntyre","year":"2023","journal-title":"World Psychiatry"},{"key":"10.1016\/j.ejphar.2026.179036_bib91","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1176\/appi.ajp.20230902","article-title":"Psychedelics for the treatment of psychiatric disorders: interpreting and translating available evidence and guidance for future research","volume":"182","author":"McIntyre","year":"2025","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.ejphar.2026.179036_bib92","doi-asserted-by":"crossref","first-page":"eabh2399","DOI":"10.1126\/sciadv.abh2399","article-title":"Psilocybin targets a common molecular mechanism for cognitive impairment and increased craving in alcoholism","volume":"7","author":"Meinhardt","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.ejphar.2026.179036_bib93","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1038\/s41593-023-01316-5","article-title":"Psychedelics promote plasticity by directly binding to BDNF receptor TrkB","volume":"26","author":"Moliner","year":"2023","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.ejphar.2026.179036_bib94","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1080\/00325481.2023.2189868","article-title":"Considerations when selecting an antidepressant: a narrative review for primary care providers treating adults with depression","volume":"135","author":"Montano","year":"2023","journal-title":"Postgrad. Med. J."},{"key":"10.1016\/j.ejphar.2026.179036_bib95","doi-asserted-by":"crossref","first-page":"15171","DOI":"10.1523\/JNEUROSCI.2063-13.2013","article-title":"Broadband cortical desynchronization underlies the human psychedelic state","volume":"33","author":"Muthukumaraswamy","year":"2013","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2026.179036_bib96","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jad.2019.07.076","article-title":"Classical psychedelics for the treatment of depression and anxiety: A systematic review","volume":"258","author":"Muttoni","year":"2019","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.ejphar.2026.179036_bib97","doi-asserted-by":"crossref","first-page":"123","DOI":"10.12688\/f1000research.9736.1","article-title":"Serotonin receptors in depression: from A to B","volume":"6","author":"Nautiyal","year":"2017","journal-title":"F1000Research"},{"key":"10.1016\/j.ejphar.2026.179036_bib98","doi-asserted-by":"crossref","first-page":"3729","DOI":"10.2147\/JIR.S317182","article-title":"Anti-inflammatory effects of four psilocybin-containing magic mushroom water extracts in vitro on 15-Lipoxygenase activity and on lipopolysaccharide-induced Cyclooxygenase-2 and inflammatory cytokines in human U937 macrophage cells","volume":"14","author":"Nkadimeng","year":"2021","journal-title":"J. Inflamm. Res."},{"key":"10.1016\/j.ejphar.2026.179036_bib99","article-title":"Predictors and risk factors of treatment-resistant depression: a systematic review","volume":"85","author":"O'Connor","year":"2023","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.ejphar.2026.179036_bib100","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ejphar.2014.07.046","article-title":"Faster, better, stronger: towards new antidepressant therapeutic strategies","volume":"753","author":"O'Leary","year":"2015","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.179036_bib101","doi-asserted-by":"crossref","DOI":"10.1177\/1179069518800508","article-title":"Psychoplastogens: a promising class of plasticity-promoting neurotherapeutics","volume":"12","author":"Olson","year":"2018","journal-title":"J. Exp. Neurosci."},{"key":"10.1016\/j.ejphar.2026.179036_bib102","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.3390\/ijms24021200","article-title":"Transcriptomic analysis of glycosylation and neuroregulatory pathways in rodent models in response to psychedelic molecules","volume":"24","author":"Oommen","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2026.179036_bib103","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0118143","article-title":"The psychedelic state induced by ayahuasca modulates the activity and connectivity of the default mode network","volume":"10","author":"Palhano-Fontes","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2026.179036_bib104","doi-asserted-by":"crossref","first-page":"273","DOI":"10.24869\/psyd.2018.273","article-title":"Challenges of treatment-resistant depression","volume":"30","author":"Pandarakalam","year":"2018","journal-title":"Psychiatr. Danub."},{"key":"10.1016\/j.ejphar.2026.179036_bib105","doi-asserted-by":"crossref","DOI":"10.3389\/fnbeh.2023.1282242","article-title":"Exploring the role of inflammation in major depressive disorder: beyond the monoamine hypothesis","volume":"17","author":"Pastis","year":"2024","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.ejphar.2026.179036_bib106","doi-asserted-by":"crossref","DOI":"10.1242\/jcs.263434","article-title":"Quantitative approaches for studying G protein-coupled receptor signalling and pharmacology","volume":"138","author":"Pearce","year":"2025","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.ejphar.2026.179036_bib107","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.3389\/fpsyg.2020.01681","article-title":"Psychedelic research and the need for transparency: polishing alice's looking glass","volume":"11","author":"Petranker","year":"2020","journal-title":"Front. Psychol."},{"key":"10.1016\/j.ejphar.2026.179036_bib108","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/sj.npp.1301574","article-title":"Stress, depression, and neuroplasticity: a convergence of mechanisms","volume":"33","author":"Pittenger","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejphar.2026.179036_bib109","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2022.104706","article-title":"The emerging science of microdosing: a systematic review of research on low dose psychedelics (1955\u20132021) and recommendations for the field","volume":"139","author":"Polito","year":"2022","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.ejphar.2026.179036_bib110","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.35082","article-title":"Changes in global and thalamic brain connectivity in LSD-induced altered states of consciousness are attributable to the 5-HT2A receptor","volume":"7","author":"Preller","year":"2018","journal-title":"eLife"},{"key":"10.1016\/j.ejphar.2026.179036_bib111","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/s41380-019-0615-x","article-title":"Neuroplasticity in cognitive and psychological mechanisms of depression: an integrative model","volume":"25","author":"Price","year":"2020","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.ejphar.2026.179036_bib112","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.phrs.2016.01.031","article-title":"Recent updates on GPCR biased agonism","volume":"112","author":"Pupo","year":"2016","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejphar.2026.179036_bib113","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1007\/s00702-018-1861-9","article-title":"Kinetics, mechanism, and inhibition of monoamine oxidase","volume":"125","author":"Ramsay","year":"2018","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.ejphar.2026.179036_bib114","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/s41398-023-02690-1","article-title":"Psilocybin-induced default mode network hypoconnectivity is blunted in alcohol-dependent rats","volume":"13","author":"Reinwald","year":"2023","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.ejphar.2026.179036_bib115","doi-asserted-by":"crossref","first-page":"2744","DOI":"10.3390\/biomedicines12122744","article-title":"Neuroplasticity and mechanisms of action of acute and chronic treatment with antidepressants in preclinical studies","volume":"12","author":"Rosas-S\u00e1nchez","year":"2024","journal-title":"Biomedicines"},{"key":"10.1016\/j.ejphar.2026.179036_bib116","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1177\/02698811231225609","article-title":"Microdosing psychedelics and the risk of cardiac fibrosis and valvulopathy: Comparison to known cardiotoxins","volume":"38","author":"Rouaud","year":"2024","journal-title":"J. Psychopharmacol. (Oxf.)"},{"key":"10.1016\/j.ejphar.2026.179036_bib117","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1002\/jcp.21246","article-title":"Mitogenic signaling pathways induced by G protein\u2010coupled receptors","volume":"213","author":"Rozengurt","year":"2007","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.ejphar.2026.179036_bib118","doi-asserted-by":"crossref","first-page":"6375","DOI":"10.3390\/molecules28176375","article-title":"Ligand-free signaling of G-Protein-Coupled receptors: physiology, pharmacology, and genetics","volume":"28","author":"Sadee","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.ejphar.2026.179036_bib119","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2023.105176","article-title":"Molecular insights into GPCR mechanisms for drugs of abuse","volume":"299","author":"Sanchez-Reyes","year":"2023","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2026.179036_bib120","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1097\/FPC.0b013e32833132cb","article-title":"Selective serotonin reuptake inhibitors pathway","volume":"19","author":"Sangkuhl","year":"2009","journal-title":"Pharmacogenet. Genom."},{"key":"10.1016\/j.ejphar.2026.179036_bib121","doi-asserted-by":"crossref","first-page":"13513","DOI":"10.1523\/JNEUROSCI.1665-10.2010","article-title":"Serotonin, but not N-methyltryptamines, activates the serotonin 2A receptor via a \u00df-arrestin2\/Src\/Akt signaling complex in vivo","volume":"30","author":"Schmid","year":"2010","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"key":"10.1016\/j.ejphar.2026.179036_bib122","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbr.2018.06.027","article-title":"Maternal stress during pregnancy induces depressive-like behavior only in female offspring and correlates to their hippocampal avp and oxt receptor expression","volume":"353","author":"Schmidt","year":"2018","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.ejphar.2026.179036_bib123","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/s41386-024-01794-6","article-title":"Antidepressant-like effects of psychedelics in a chronic despair mouse model: is the 5-HT2A receptor the unique player?","volume":"49","author":"Sekssaoui","year":"2024","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejphar.2026.179036_bib124","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1016\/j.neuron.2021.06.008","article-title":"Psilocybin induces rapid and persistent growth of dendritic spines in frontal cortex in vivo","volume":"109","author":"Shao","year":"2021","journal-title":"Neuron"},{"key":"10.1016\/j.ejphar.2026.179036_bib125","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.bbr.2019.03.009","article-title":"Repeated fluoxetine treatment induces long-lasting neurotrophic changes in the medial prefrontal cortex of adult rats","volume":"365","author":"Song","year":"2019","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.ejphar.2026.179036_bib126","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1176\/appi.ajp.2020.20030280","article-title":"Toward circuit mechanisms of pathophysiology in depression","volume":"177","author":"Spellman","year":"2020","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.ejphar.2026.179036_bib127","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1136\/medethics-2021-107262","article-title":"Research abuses against people of colour and other vulnerable groups in early psychedelic research","volume":"48","author":"Strauss","year":"2022","journal-title":"J. Med. Ethics"},{"key":"10.1016\/j.ejphar.2026.179036_bib128","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2015.00358","article-title":"Psychedelics and immunomodulation: novel approaches and therapeutic opportunities","volume":"6","author":"Szabo","year":"2015","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejphar.2026.179036_bib129","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1007\/s43440-024-00660-y","article-title":"Psilocybin and the glutamatergic pathway: implications for the treatment of neuropsychiatric diseases","volume":"76","author":"Szpr\u0119giel","year":"2024","journal-title":"Pharmacol. Rep. PR"},{"key":"10.1016\/j.ejphar.2026.179036_bib130","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/0020-708X(85)90257-1","article-title":"11C-labeling of indolealkylamine alkaloids and the comparative study of their tissue distributions","volume":"36","author":"Takahashi","year":"1985","journal-title":"Int. J. Appl. Radiat. Isot."},{"key":"10.1016\/j.ejphar.2026.179036_bib131","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2020.113049","article-title":"Relationships between depressive symptoms, other psychological symptoms, and quality of life","volume":"289","author":"Tang","year":"2020","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.ejphar.2026.179036_bib132","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1038\/s41380-022-01520-y","article-title":"Dysregulation of adult hippocampal neuroplasticity in major depression: pathogenesis and therapeutic implications","volume":"27","author":"Tartt","year":"2022","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.ejphar.2026.179036_bib133","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1126\/science.adf0435","article-title":"Psychedelics promote neuroplasticity through the activation of intracellular 5-HT2A receptors","volume":"379","author":"Vargas","year":"2023","journal-title":"Science"},{"key":"10.1016\/j.ejphar.2026.179036_bib134","doi-asserted-by":"crossref","first-page":"3897","DOI":"10.1097\/00001756-199812010-00024","article-title":"Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action","volume":"9","author":"Vollenweider","year":"1998","journal-title":"Neuroreport"},{"key":"10.1016\/j.ejphar.2026.179036_bib135","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.cell.2016.12.033","article-title":"Crystal structure of an LSD-bound human serotonin receptor","volume":"168","author":"Wacker","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.ejphar.2026.179036_bib136","doi-asserted-by":"crossref","first-page":"8221","DOI":"10.1038\/s41467-023-44016-1","article-title":"Identification of 5-HT2A receptor signaling pathways associated with psychedelic potential","volume":"14","author":"Wallach","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejphar.2026.179036_bib137","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/s12974-022-02492-0","article-title":"Microglia in depression: an overview of microglia in the pathogenesis and treatment of depression","volume":"19","author":"Wang","year":"2022","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.ejphar.2026.179036_bib138","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.ibneur.2022.09.001","article-title":"Neural plasticity and depression treatment","volume":"14","author":"Wang","year":"2023","journal-title":"IBRO Neurosci. Rep"},{"key":"10.1016\/j.ejphar.2026.179036_bib139","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/s41586-024-07403-2","article-title":"Structural pharmacology and therapeutic potential of 5-methoxytryptamines","volume":"630","author":"Warren","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2026.179036_bib140","doi-asserted-by":"crossref","first-page":"5084","DOI":"10.3390\/molecules29215084","article-title":"Psilocin, the psychoactive metabolite of psilocybin, modulates select neuroimmune functions of microglial cells in a 5-HT2 receptor-dependent manner","volume":"29","author":"Wiens","year":"2024","journal-title":"Molecules"},{"key":"10.1016\/j.ejphar.2026.179036_bib141","first-page":"79","article-title":"Serotonin 5-HT2A receptors are expressed on pyramidal cells and interneurons in the rat cortex","volume":"27","author":"Willins","year":"1997","journal-title":"Synap. N. Y. N"},{"key":"10.1016\/j.ejphar.2026.179036_bib142","doi-asserted-by":"crossref","first-page":"6713","DOI":"10.3390\/ijms23126713","article-title":"Effect of psilocybin and ketamine on brain neurotransmitters, glutamate receptors, DNA and rat behavior","volume":"23","author":"Wojtas","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2026.179036_bib143","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/s41580-018-0049-3","article-title":"Mechanisms of signalling and biased agonism in G protein-coupled receptors","volume":"19","author":"Wootten","year":"2018","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ejphar.2026.179036_bib144","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1021\/acschemneuro.7b00490","article-title":"What contributes to serotonin\u2013norepinephrine reuptake inhibitors' dual-targeting mechanism? The key role of transmembrane domain 6 in human serotonin and norepinephrine transporters revealed by molecular dynamics simulation","volume":"9","author":"Xue","year":"2018","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ejphar.2026.179036_bib145","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1021\/acsptsci.0c00194","article-title":"The subjective effects of psychedelics are necessary for their enduring therapeutic effects","volume":"4","author":"Yaden","year":"2021","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"10.1016\/j.ejphar.2026.179036_bib146","doi-asserted-by":"crossref","first-page":"418","DOI":"10.37349\/en.2024.00058","article-title":"Psychedelics as novel therapeutic agents for chronic pain: mechanisms and future perspectives","volume":"3","author":"Yasin","year":"2024","journal-title":"Explor. Neurosci."},{"key":"10.1016\/j.ejphar.2026.179036_bib147","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1124\/jpet.108.143461","article-title":"Serotonin 5-Hydroxytryptamine2A receptor activation suppresses tumor necrosis Factor-\u03b1-Induced inflammation with extraordinary potency","volume":"327","author":"Yu","year":"2008","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejphar.2026.179036_bib148","doi-asserted-by":"crossref","first-page":"2624","DOI":"10.3390\/molecules28062624","article-title":"The effect of combined treatment of psilocybin and eugenol on lipopolysaccharide-induced brain inflammation in mice","volume":"28","author":"Zanikov","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.ejphar.2026.179036_bib149","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/s41392-024-01803-6","article-title":"G protein-coupled receptors (GPCRs): advances in structures, mechanisms and drug discovery","volume":"9","author":"Zhang","year":"2024","journal-title":"Signal Transduct. Targeted Ther."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299926005182?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299926005182?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T12:10:45Z","timestamp":1784808645000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299926005182"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":149,"alternative-id":["S0014299926005182"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2026.179036","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antidepressant effect of psychedelic compounds and mechanisms underlying the G protein-coupled receptors activation psychedelics: Antidepressant action and GPCR signaling","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2026.179036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"179036"}}